These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7825646)

  • 21. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal aberrations level in peripheral blood lymphocytes of women with polycystic ovary syndrome.
    Nersesyan A; Martirosyan A; Parsadanyan G; Zalinyan G
    J BUON; 2006; 11(4):477-80. PubMed ID: 17309180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.
    Dunaif A
    Am J Med; 1995 Jan; 98(1A):33S-39S. PubMed ID: 7825639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the association of the T869C polymorphism of the transforming growth factor-β1 gene with polycystic ovary syndrome.
    Park JH; Li L; Baek KH
    Mol Med Rep; 2015 Sep; 12(3):4560-4565. PubMed ID: 26059110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S; McCarthy MI; Hardy K
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovaries - beyond menopause.
    Shah D; Bansal S
    Climacteric; 2014 Apr; 17(2):109-15. PubMed ID: 23895379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genetic basis of polycystic ovary syndrome.
    Franks S; Gharani N; Waterworth D; Batty S; White D; Williamson R; McCarthy M
    Hum Reprod; 1997 Dec; 12(12):2641-8. PubMed ID: 9455828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic features of polycystic ovary syndrome in adolescents (review).
    Beltadze K; Barbakadze L
    Georgian Med News; 2015 Jan; (238):32-4. PubMed ID: 25693210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Body composition and polycystic ovary syndrome].
    Zabuliene L; Tutkuviene J
    Medicina (Kaunas); 2010; 46(2):142-57. PubMed ID: 20440089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Search for the etiopathogenesis of polycystic ovary syndrome (PCOS)].
    Wertheim K; Sobczyńska-Tomaszewska A; Bal J
    Ginekol Pol; 2007 Aug; 78(8):626-31. PubMed ID: 18050612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.
    Westerveld HE; Hoogendoorn M; de Jong AW; Goverde AJ; Fauser BC; Dallinga-Thie GM
    Pharmacol Ther; 2008 Sep; 119(3):223-41. PubMed ID: 18602948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence of metabolic syndrome in adolescents with different phenotypes of PCOS.
    Altintas KZ; Dilbaz B; Cirik DA; Ozelci R; Zengin T; Erginay ON; Dilbaz S
    Ginekol Pol; 2017; 88(6):289-295. PubMed ID: 28727126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.
    Peppard HR; Marfori J; Iuorno MJ; Nestler JE
    Diabetes Care; 2001 Jun; 24(6):1050-2. PubMed ID: 11375369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polycystic ovary syndrome: is there a rise in the prevalence?].
    Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
    Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.